Evidence map›Paper›PMID 26391088›Full record

SynthesisProstate cancer and prostatic diseases2016

Metabolic syndrome, inflammation and lower urinary tract symptoms: possible translational links.

Q He, Z Wang, G Liu, F Daneshgari, G T MacLennan, S Gupta

Abstract readSystematic Review
In one paragraph

Synthesis in Prostate cancer and prostatic diseases, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 66 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
66citing papers in PubMed, 2 pooled it
7.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

66 citing papers in PubMed, 2 syntheses or guidelines pooled it, 110 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Mitochondrial dysfunction in urologic disease.Prostate cancer and prostatic diseases · 2026
    Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

6 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Q HeDepartment of Urology, Case Western Reserve University and University Hospitals Case Medical Center, Cleveland, OH, USA.
Z WangDepartment of Urology, Key Laboratory of Disease of Urological Systems, Gansu Nephro-Urological Clinical Center, Second Hospital of Lanzhou University, Lanzhou, Gansu, China.
G LiuDepartment of Surgery, MetroHealth Medical Center, Case Western Reserve University, Cleveland, OH, USA.
F DaneshgariDepartment of Surgery, MetroHealth Medical Center, Case Western Reserve University, Cleveland, OH, USA.
G T MacLennanDepartment of Pathology, Case Western Reserve University and University Hospitals Case Medical Center, Cleveland, OH, USA.
S GuptaDepartment of Urology, Case Western Reserve University and University Hospitals Case Medical Center, Cleveland, OH, USA.
Case Western Reserve University · USLanzhou University · CNLanzhou University Second Hospital · CNUniversity Hospitals Case Medical Center · US

Funding

Urological Complications of Obesity and DiabetesP20DK090871 · NIDDK · CASE WESTERN RESERVE UNIVERSITY · PI DANESHGARI, FIROUZ · 2010 to 2011
$556k
NIDDK NIH HHS P20 DK090871NIDDK NIH HHS P20DK090871
6 · The paper itself

Abstract

backgroundEpidemiological data suggest that lower urinary tract symptoms (LUTSs) may be associated with metabolic syndrome (MetS). Inflammation has been proposed as a candidate mechanism at the crossroad between these two clinical entities. The aim of this review article is to evaluate the role of MetS-induced inflammation in the pathogenesis and progression of LUTS.

methodsA systematic review was conducted using the keywords 'metabolic syndrome and lower urinary tract symptoms' within the title search engines including PubMed, Web of Science and the Cochrane Library for relevant research work published between 2000 and January 2015. The obtained literature was reviewed by the primary author (QH) and was assessed for eligibility and standard level of evidence.

resultsTotal of 52 articles met the eligibility criteria. On the basis of database search during the past 15 years and our systematic review of prospective and retrospective cohorts, case-control trials, observational studies and animal data identified a possible link between MetS-induced inflammation and LUTS including BPH, bladder outlet obstruction, overactive bladder, urinary incontinence and other possible urinary tract abnormalities.

conclusionsThere is convincing evidence to suggest that MetS and inflammation could be important contributors to LUTS in men, particularly in the development of BPH. However, the role of MetS-induced inflammation remains unclear in overactive bladder, urinary incontinence and etiology of LUTS progression.

Indexed as

HumansInflammationLower Urinary Tract SymptomsMaleMetabolic SyndromeProstateProstatic HyperplasiaProstatic NeoplasmsUrinary Bladder

Identifiers

PMID26391088
PMCPMC4747786
OpenAlexW2247131120

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.